The ASX200 benchmark index has ended the week and February higher
\nIT was far and away the best-performing sector
\nNyrada was best of the Small Caps by a fair few lengths<\/p>\n
\u00a0<\/p>\n
It was a dramatic week on the local market and, personally \u2013 despite some satisfactorily mad small cap action on Wednesday \u2013 I thought Thursday took the cake when the benchmark staged a late arvo rally.<\/p>\n
But first, this is how the ASX200 (XJO) index looked at 3.30pm on Friday.<\/p>\n
<\/strong><\/p>\n The broader ASX All Ordinaries (XAO) index ended Thursday up 42.5 points, or 0.55% to 7,959.5, the XAO\u2019s highest close ever.<\/p>\n It was the last day of February and fundies had a fair bit on the line \u2013 as did local markets \u2013 which surged 0.5% higher at the close to keep in place its monthly winning streak.<\/p>\n Then there was the new intraday record high that the benchmark S&P\/ASX200 index slapped into, smooching its previous intraday high of 7,703.6 from February 2.<\/p>\n And so the benchmark began Friday at 7,698.7, mere teeth-skins away from its best-ever close of 7,699.4, (also from early February).<\/p>\n Friday dealt with that record at the open. Then it ran away. Then it surged past it. As I said. It\u2019s been pretty real.<\/p>\n\n But back to Thursday\u2026<\/strong><\/em><\/p>\n Flummoxed at the open, the index quickly shed weight before a sudden urge to pile in spread with the warmth, speed and surprise of middle-age incontinence \u2013 likely inspired by sleepy \u2018sophisticated\u2019 and institutional traders who suddenly realised they need to rake in some action ahead of months-end portfolio readjusting.<\/p>\n So the week was positive and the month snuck home as well, with the ASX200 ending February up 0.2%, its fourth straight month of gains\u2026<\/p>\n<\/div>\n Via MarketIndex<\/em><\/p>\n Eight of the ASX\u2019s 11 sectors finished higher this week, with the interest-rate-sensitive sectors surging.<\/p>\n Needless to say it\u2019s been a week and a month indeed for ASX Tech.<\/p>\n<\/div>\n Via MarketIndex<\/em><\/p>\n \u00a0<\/p>\n A lot of exciting stories behind stock movements during a heavy week of earnings, drama and ex-dividends.<\/p>\n After discovering it was under the regulatory spotlight on Monday for a second government-led inquiry in two years, the naughty casino giant Star Entertainment Group surged by double digits after returning (perhaps briefly) to profitability in the first half with a $9.1mn stat profit.<\/p>\n That\u2019s quite an improvement on the $1.3 billion<\/em> loss a year ago.<\/p>\n Stock of the week\u2026<\/strong><\/em><\/p>\n<\/div>\n Earlier this week, we were fortunate enough to chat with the chief executive, chemist and small molecule maker, the man behind the monster \u2013 Aussie drug making minnow, Nyrada (ASX:NYR)<\/strong><\/a>.<\/p>\n Stock in the biopharmaceutical company \u2013 a specialist in \u201cnovel small molecule therapeutics\u201d on Thursday morning announced positive results from its preclinical study evaluating the efficacy of its brain trauma program drug candidate NYR-BI03 in preventing secondary brain injury.<\/p>\n CEO James Bonnar told Stockhead<\/em> NYR has been applying its work in small molecules with an eye to helping the many, many people suffering from neurological and cardiovascular diseases.<\/p>\n Here\u2019s what the trained chemist (\u201cI make a good small molecule\u201d) summarised as three reasons behind the company\u2019s extraordinary outperformance.<\/p>\n \u201cThe results from our stroke study are powerful for three reasons,\u201d James told Stockhead <\/em>on Wednesday arvo.<\/p>\n \u201cFirstly, the drug candidate is a first-in-class molecule which means it offers a new therapeutic approach to treating brain injury.<\/p>\n \u201cSecondly, the pathology behind brain injury is common across both stroke and traumatic brain injuries, such as those caused by a car accident, sports injury or military wound. This means our drug candidate has potential for treating patients in two important markets: stroke and traumatic brain injury.<\/p>\n \u201cLastly, the target our drug candidate hits is novel, making Nyrada pioneers in an area that no other biotech is currently working in, to our knowledge.\u201d<\/p>\n For those still searching the skies for traces of Nyrada as it leaves the ionosphere\u2026 NYR earlier today released new data from it\u2019s brain injury drug candidate (NYR-BI03) and has since lapped local markets and continued ever skywards.<\/p>\n A picture perhaps does the scene more justice.<\/p>\n This was Nyrada vs the ASX on Wednesday:<\/strong><\/em><\/p>\n \u00a0<\/p>\n Via Google<\/em><\/p>\n \u00a0<\/p>\n And that, lads and ladies, is why small caps are best.<\/p>\n So\u2026 who won the week? Let\u2019s find out together\u2026<\/strong><\/em><\/p>\n \u00a0<\/p>\n Code Company Price % Week Market Cap NYR Nyrada Inc 0.09 309% $15,132,844 WHK Whitehawk Limited 0.036 200% $10,480,192 TD1 Tali Digital Limited 0.002 100% $4,942,733 VPR Volt Power Group 0.002 100% $21,432,416 AUA Audeara 0.058 76% $8,098,033 ENV Enova Mining Limited 0.05 67% $29,482,750 MAG Magmatic Resrce Ltd 0.05 67% $15,284,640 CUE CUE Energy Resource 0.1 56% $69,811,972 ADS Adslot Ltd. 0.003 50% $9,673,487 AOA Ausmon Resources 0.003 50% $3,176,998 EXL Elixinol Wellness 0.009 50% $5,062,973 RBR RBR Group Ltd 0.003 50% $4,855,214 SIH Sihayo Gold Limited 0.0015 50% $18,306,384 SIT Site Group Int Ltd 0.003 50% $7,807,471 5EA 5Eadvanced 0.27 50% $90,819,668 AMD Arrow Minerals 0.006 50% $40,102,591 SRX Sierra Rutile 0.0995 49% $35,635,862 SCN Scorpion Minerals 0.025 47% $7,370,211 OXT Orexplore Technologies 0.029 45% $4,689,976 GHY Gold Hydrogen 1.585 45% $119,594,316 AQI Alicanto Minerals 0.033 43% $15,998,757 REM Remsense Technologies 0.03 43% $2,702,378 APX Appen Limited 0.55 43% $123,871,657 GT1 Greentechnology 0.185 42% $51,000,336 DCC Digitalx Limited 0.071 42% $53,536,370 29M 29Metals 0.37 37% $259,486,672 ANR Anatara Ls Ltd 0.03 36% $4,197,343 ICR Intelicare Holdings 0.019 36% $4,461,665 PNN Power Minerals Ltd 0.21 35% $18,348,981 IAM Income Asset 0.09 34% $29,778,374 AIM Ai-Media Technologie 0.375 34% $77,261,197 AHN Athena Resources 0.004 33% $3,211,403 BP8 BPH Global Ltd 0.002 33% $3,908,232 FFF Forbidden Foods 0.016 33% $3,229,769 FTC Fintech Chain Ltd 0.02 33% $13,015,392 HLX Helix Resources 0.004 33% $9,292,583 RIE Riedel Resources Ltd 0.004 33% $8,895,343 SRY Story-I Limited 0.004 33% $1,505,619 LEL Lithenergy 0.585 33% $61,290,950 GL1 Global Lithium 0.66 32% $154,857,853 ADH Adairs Limited 2.38 32% $415,322,357 GLV Global Oil & Gas 0.021 31% $9,807,007 LGM Legacy Minerals 0.17 31% $16,345,525 PER Percheron 0.09 30% $78,434,412 WC8 Wildcat Resources 0.7625 30% $878,941,020 VMS Venture Minerals 0.0195 30% $37,683,555 HRZ Horizon 0.04 29% $29,441,314 WR1 Winsome Resources 0.895 29% $163,121,219 ASP Aspermont Limited 0.009 29% $22,100,712 KGN Kogan.Com Ltd 7.9 28% $801,363,002 <\/p>\n WordPress Table Plugin<\/a><\/p>\n As mentioned above, local biopharma and novel small molecule therapeutics specialising in treating neurological and cardiovascular diseases Nyrada (ASX:NYR)<\/strong><\/a> absolutely left orbit after announcing positive results from its preclinical study evaluating the efficacy of its brain injury program drug candidate NYR-BI03.<\/p>\n \u00a0<\/p>\n Already lurching higher on Friday, the local cybersecurity minnow\u00a0WhiteHawk (ASX:WHK)<\/span><\/a> continued its fearsome run as the AI-related small cap of choice to ride the tail of Nvidia\u2019s success on Wall Street.<\/p>\n The ASX lobbed a seedng ticket WHK\u2019s way which it confidently rebuffed with a handy self-description\u2026<\/p>\n This is what WHK says about WHK:<\/p>\n WhiteHawk is a cloud-based cyber security exchange platform that delivers Artificial Intelligence based Cyber Risk Profile\u2019s, interactive online maturity models, tailored Cyber Risk Scorecard reports, matching to innovative products, solutions and best practices, all via an intuitive virtual consult.<\/em><\/p>\n The platform enables customers to leverage their tailored Security Story to find affordable and impactful cyber tools, non-technical context, and relevant services through our algorithms, online customer journey and accessible expertise.<\/em><\/p>\n This is what WHK says when the ASX gives it a parking ticket and demands to know why its stock is so stonkingly high\u2026 (the cool logo comes free of charge)<\/p>\n Via ASX<\/em><\/p>\n The critical minerals hunter <\/span>Enova Mining (ASX:ENV)<\/strong><\/a> entered into a binding option agreement with a private individual \u2013 one Rodrigo de Brito Mello \u2013 to acquire 100% of the huge, 153.3km2 CODA <\/span>prospect.\u00a0<\/span><\/p>\n Located in the mining heavy state of Minas Gerais in Brazil, CODA\u00a0is viewed by Enova as a potential world class \u201cdistrict sized\u201d ionic clay rare earths project.<\/p>\n So far, 11 shallow auger holes have been drilled within the CODA prospect, with the most significant results revealing the following:<\/p>\n \u2022 10.5m at 2,567 ppm TREO including 4.5m at 4,157 ppm TREO The highest assaying drill intercepts were recorded at end of hole: 0.5m at 5,697 ppm TREO and 1m at 5,078 ppm TREO.<\/p>\n Enova reports that mineralisation remains open in all directions at CODA with grades significantly increasing at depth.<\/p>\n Code Company Price % Week Market Cap CMD Cassius Mining Ltd 0.01 -70% $5,420,045 DCX Discovex Res Ltd 0.001 -50% $3,302,568 KNB Koonenberry Gold 0.015 -44% $1,796,236 VIT Vitura Health Ltd 0.135 -44% $80,622,330 LNR Lanthanein Resources 0.0035 -42% $6,449,060 NME Nex Metals Exploration 0.013 -38% $4,582,923 ARR American Rare Earths 0.26 -38% $125,822,941 E79 E79Goldmineslimited 0.044 -37% $3,497,366 JAY Jayride Group 0.012 -37% $3,072,019 ME1 Melodiol Global Health 0.007 -36% $2,750,973 DGL DGL Group Limited 0.685 -34% $199,609,523 RIL Redivium Limited 0.003 -33% $8,192,564 TMG Trigg Minerals Ltd 0.006 -33% $2,623,293 ASH Ashley Services Grp 0.25 -32% $33,114,458 ATG Articore Group Ltd 0.5 -32% $144,219,477 TNY Tinybeans Group Ltd 0.105 -32% $10,548,418 W2V Way2Vat 0.021 -32% $12,380,560 VBS Vectus Biosystems 0.2 -32% $13,302,340 CDX Cardiex Limited 0.082 -32% $22,945,616 SOC Soco Corporation 0.12 -31% $15,898,780 CPO Culpeo Minerals 0.043 -31% $6,900,133 UCM Uscom Limited 0.023 -30% $5,716,007 WYX Western Yilgarn NL 0.062 -29% $3,227,738 NRZ Neurizer Ltd 0.005 -29% $5,855,643 ACE Acusensus Limited 0.795 -28% $103,647,980 NXD Nexted Group Limited 0.385 -28% $83,068,790 PTR Petratherm Ltd 0.021 -28% $4,944,525 APL Associate Global 0.08 -27% $5,366,780 FRX Flexiroam Limited 0.016 -27% $11,890,929 PPG Pro-Pac Packaging 0.205 -27% $40,879,735 ICL Iceni Gold 0.026 -26% $4,684,660 1MC Morella Corporation 0.003 -25% $24,715,198 AUZ Australian Mines Ltd 0.0165 -25% $18,080,631 HCD Hydrocarbon Dynamic 0.003 -25% $3,234,329 HGL Hudson Investment 0.15 -25% $8,903,990 MOZ Mosaic Brands Ltd 0.15 -25% $26,775,966 RNX Renegade Exploration 0.006 -25% $7,012,066 TKL Traka Resources 0.0015 -25% $2,625,988 WFL Wellfully Limited 0.003 -25% $1,478,832 COB Cobalt Blue Ltd 0.135 -25% $50,733,947 E25 Element 25 Ltd 0.195 -25% $45,681,370 ZNC Zenith Minerals Ltd 0.071 -24% $29,952,375 CNB Carnaby Resource Ltd 0.4575 -24% $73,280,852 RDM Red Metal Limited 0.1475 -24% $46,367,986 MGU Magnum Mining & Exp 0.016 -24% $16,187,228 IIQ Inoviq Ltd 0.6325 -23% $62,572,717 WBE Whitebark Energy 0.017 -23% $2,619,874 AVM Advance Metals Ltd 0.031 -23% $1,242,634 AVA AVA Risk Group Ltd 0.155 -23% $40,981,779 OPN Openn Negotiation 0.007 -22% $9,033,437 <\/p>\n WordPress Table Plugin<\/a><\/p>\n \u00a0<\/p>\n Monday 26 February, 2024<\/strong><\/p>\n Enova and Whitehawk stole the show on Monday, while\u00a0Aussie tech-debt collection provider Credit Clear (ASX:CCR)<\/strong><\/a> did a decent backup.<\/p>\n CCR upgraded guidance for FY24 following a strong 1H\u201924 result, which included better margins, revenue, mre customers and a decent balance sheet.<\/p>\n CCR is now tracking ahead of FY24 guidance, and consequently here\u2019s the newly upgraded forecast:<\/p>\n FY24 revenue guidance up from $39m \u2013 $41m to $40m \u2013 $42m, and FY24 Underlying EBITDA1 guidance up from $1m \u2013 $2m to in excess of $3m.<\/p>\n CCR revenue jumped up 15% pcp to over $20mn; Underlying EBITDA improved some $1.8m on the pcp and Statutory EBITDA improved $5.4m on pcp; Gross margin expanded to 54%, up from 50% in 1H\u201923 .<\/p>\n CCR says it signed on 225 new clients, a 24% increase on pcp, including tier-1 clients in banking, insurance, and essential services (utilities).<\/p>\n And we all like a strong balance sheet: CCR now has $13m cash at the bank, an improvement of $3.7m on pcp.<\/p>\n Investors liked a lot of that.<\/p>\n Also doing quite well was Cygnus Metals (ASX:CY5)<\/a><\/strong>.<\/p>\n The diversified minerals hunter says first drilling has taken place at the Pegasus prospect within its high-priority Auclair lithium project in James Bay, Quebec in Canada.<\/p>\n And it\u2019s reporting some \u201cstrong visual results\u201d, revealing, it says, numerous thick and shallow spodumene-bearing pegmatite intersections up to 77m wide, with an average width of 38m.<\/p>\n The best mineralised section of the drill core appears to be 43.7m of pegmatite with average 10-12% estimated spodumene mineralisation from 46.4m. That includes 3.3m with 60-70% estimated spodumene mineralisation from 83.5m.<\/p>\n Assays are pending, of course, and those are expected in Q2.<\/p>\n \u00a0<\/p>\n Tuesday 27 February, 2024<\/strong><\/p>\n Up circa 90% is the Aussie \u201cglobal hearing health leader specialising in innovative listening solutions for people with hearing challenges\u201d, \u2013 (that\u2019ll be you Mr\u00a0Audeara (ASX:AUA)<\/strong><\/a>) has made a groundbreaking, milestone-making maiden sale \u2013\u00a0 to mass manufacture AUA audio tech for Avedis Zildjian.<\/p>\n The maiden third party purchase order of $2.1m is also the largest single order Audeara has received since inception.<\/p>\n AUA co-founder and CTO Alex Afflick says the purchase\u00a0 is \u201cexpected to have a significant positive impact on the Company\u2019s cashflow and its push toward breakeven and profitability.\u201d<\/p>\n First announced early last year, the project AUA says, is nearing mass production, ahead of a commercial launch\u00a0anticipated in H1 FY25.<\/p>\n OD6 Metals (ASX:OD6)<\/strong><\/a>\u00a0says it\u2019s just pumped about the quality of the metallurgical recoveries from samples tested at the Australian Nuclear Science Organisation (ANSTO), including \u2013 apparently \u2013 up to 90% of Magnet Rare Earth Elements (MagREE) in multiple Prospect areas, across 60 new samples.<\/p>\n Lots and lots happening out of these samples from Splinter Rock with OD6 claiming that recoveries for all MagREO are inclusive of Nd, Pr, Dy, Tb similar.<\/p>\n This is the key to overall project economics for any clay hosted rare earth project.<\/p>\n MD Brett Hazelden says the metrics align closely with the essential value drivers we believe are crucial for the economic viability of clay-hosted rare earth projects.<\/p>\n \u201cThe outstanding results from our metallurgical leaching studies continue to affirm the Splinter Rock project as Australia\u2019s premier clay-hosted rare earth deposit. With consistent recoveries averaging over 60% across multiple prospects, and notably high recoveries observed for each of the fifteen rare earth elements, our confidence in the project\u2019s potential remains high.\u201d<\/p>\n Meanwhile, battery metals stocks have been crunched lately, but one brave US-based ASX battery metals player is taking care of Tuesday\u00a0 with a startlingly comprehensive update on progress at the 5E Boron Americas Complex in California.<\/p>\n Word is: it remains on track to kickstart commercial operations at the new boron and lithium mine in California in the second quarter of this year.<\/p>\n 5E Advanced Materials (ASX:5EA)<\/strong><\/a>\u00a0is planning to open what will be only the second major boric acid operation in America. The other is a non-core asset owned and operated by\u00a0Rio Tinto (ASX:RIO)<\/strong><\/a>\u00a0which has been in business since 1927.<\/p>\n 5EA CEO Susan Brennan says the company remains on track to start commercial ops in CY Q2 2024, with all mining operations and related activities on track as it moves closer to initial boron and lithium production.<\/p>\n Just how big a deal is it, Ms Brennan?<\/p>\n \u201cI cannot emphasise enough the importance 5E will represent in the US in the coming months as a new and secure producer of critical materials needed for clean energy economies.\u201d<\/p>\n That\u2019s how much.<\/p>\n And new sources of the \u2018supermaterial\u2019 \u2014 used alongside rare earths metals in permanent magnets, fire retardants, ceramics, fertiliser, detergent and more \u2014 are essential given the concentrated nature of the market.<\/p>\n 5EA began mining at its Boron Americas Complex at Fort Cady last month, where it plans to produce 2000tpa of boric acid and 100tpa of lithium carbonate from a starter plant in 2024 before ramping up in a US$389m expansion to 90,000tpa and 1100tpa in 2026.<\/p>\n Finally, a shout out to\u00a0Elixinol Wellness (ASX:EXL)<\/strong><\/a>, which is up about 88%. It could be the Germans. or it could be that this is just a stunner of a prospects\u2026<\/p>\n \u00a0<\/p>\n Wednesday 28 February, 2024<\/strong><\/p>\n Making big moves on the same day as Nyrada was\u00a0 the everywhere-listed EcoGraf (ASX:EGR)<\/strong><\/a>\u00a0after reporting positive findings from a research program completed by the Helmholtz Institute in Germany, where EcoGraf \u2018s proprietary processing technology has been used to purify graphite particles recovered from end-of-life lithium-ion batteries.<\/p>\n EcoGraf purified the recovered graphite particles to battery grade specification.<\/p>\n The German Government funded program then compared the electrochemical performance of (the recycled)\u00a0EcoGraf HFfree<\/strong>\u00a0graphite with a number of commercial battery graphite products. And there was much rejoicing.<\/p>\n The company says further research is required before anyone sells the house.<\/p>\n And, 5E Advanced Materials (ASX:5EA)<\/strong><\/a> was still<\/em>\u00a0killing it on Wednesday.<\/p>\n \u00a0<\/p>\n Thursday 29 February, 2024<\/strong><\/p>\n A strong run over 1H for Motio has traders diving in. Revenues of $3,675,500 are up 31%.<\/p>\n A chuffed CEO and MD Adam Cadwallader told investors that Motio is growing.<\/p>\n \u201cThe business has increased its revenue per location this half across each of its media channels. Motio\u2019s software and payments platform (Spawtz) has achieved all of its growth revenue targets and business development KPI\u2019s this half year, which has been extremely pleasing.\u201d<\/p>\n Struggling\u00a0Sierra Rutile (ASX:SRX)<\/strong><\/a>\u00a0has swung to a more than $20mn 1H loss, with a nasty combination of weak market conditions and uncertainties around everything from Area 1 fiscal terms to power availability which has left the company betweedn rutile and a hard place.<\/p>\n However the stock has surged after Sierra flagged a suspension of operations from 11 March, and given notice of a redundancy programme \u201canticipated to impact 25-30% of the workforce.\u201d<\/p>\n We\u2019ve got gains for\u00a0Cue Energy Resources (ASX:CUE)<\/a>\u00a0\u2013 up early in the morning after delivering its half-year, with a 22% lift in revenue to $29.3 million, and an underlying EBITDAX of $19.3 million, up 21%, and a 34% NPAT increase to $9.1 million.<\/p>\n Noxopharm (ASX:NOX)<\/strong><\/a>\u00a0is continuing its recent run of good form, up another 28.2% after it banked some happy 1HFY24 results news yesterday.<\/p>\n Ardea Resources (ASX:ARL)<\/a>\u00a0and its Japanese consortium partners have reached an agreement on the scope and budget for the Kalgoorlie Nickel Project \u2013 Goongarrie Hub Definitive Feasibility Study. The Consortium has advised Ardea that they have completed their due diligence, and a final investment decision is in the works.<\/p>\n Norfolk Metals (ASX:NFL)<\/a>\u00a0is also higher after an upbeat projects update for its copper-gold play in Tasmania, and an expansion to its uranium exploration in South Australia.<\/p>\n Friday 01 March, 2024<\/strong><\/p>\n Tony Sage\u2019s\u00a0European Lithium (ASX:EUR)<\/a>\u00a0has announced publicly traded special purpose acquisition company Sizzle Corp (NASDAQ:SZZL) and EUR\u2019s Wolfsberg lithium project in Austria have officially merged to form Critical Minerals Corp.<\/p>\n Critical Metals started trading on the NASADAQ on February 28 under the ticker CRML with the Wolfsberg lithium project in Austria becoming its initial flagship asset with the mine\u2019s future construction and commissioning a key focus.<\/p>\n Family safety app\u00a0Life360 (ASX:360)<\/a>\u00a0has announced its quarter and CY23 results including revenue of $305 million, a YoY increase of 33%, in line with guidance of $300 million-$310 million and core Life360 subscription revenue of $200 million, up 52% YoY. Net loss of $28.2 million was a $63.5 million improvement from CY22.<\/p>\n Focused on project development of low-emission fuels and energy materials\u00a0Hexagon Energy Materials (ASX:HXG)<\/a>\u00a0 says it progressed confidential commercial discussions with potential strategic partners regarding its WAH2 project and received indicative pricing for several key aspects of the project during the December quarter.<\/p>\n \u00a0<\/p>\n \u00a0<\/p>\n <\/span><\/p>\n The post ASX Small Caps and IPO Weekly Wrap: Tech stocks surged +20pc last month, but the week belonged to Nyrada<\/a> appeared first on Stockhead<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"The ASX in February<\/h2>\n
ASX Sectors this week<\/h2>\n
ASX SMALL CAP WINNERS THIS WEEK<\/h2>\n
<\/h2>\n
\n\u2022 10m at 3,218 ppm TREO including 6m at 3,608 ppm TREO
\n\u2022 10m at 2,414 ppm TREO including 4m at 4,401 ppm TREO<\/p>\nASX SMALL CAP LAGGARDS THIS WEEK<\/h2>\n
HOW THE WEEK SHOOK OUT<\/h2>\n
<\/h2>\n